Diagnostic Testing and Understanding Your Genetics

Getting a clear diagnosis for CLN4 is a technical challenge that requires more than a simple blood test. Because the mutations that cause this disease are unique and sometimes “hide” from standard equipment, understanding the specifics of your genetic report is the most important step in confirming your diagnosis.

Why Standard Tests Often Fail

Most genetic diagnoses are found using Whole Exome Sequencing (WES) or Sanger sequencing. While these are powerful tools, they have a known “blind spot” when it comes to CLN4 ^[1].

While various pathogenic variants in the DNAJC5 gene can cause CLN4 (such as recurrent insertions, deletions, or duplications), some specific complex mutations can be technically difficult to detect ^[1]. Standard tests can miss this for a few reasons:

• Allelic Dropout: During testing, the laboratory assay might preferentially amplify or capture the shorter, healthy version of the gene and completely ignore the longer, mutated version. This is called allelic dropout, and it can lead to a false negative result ^[1][2].
• Complex Regions: The area of the gene where these mutations happen (the cysteine-string domain) can be difficult for standard sequencers to read accurately ^[1].

If your initial genetic test was negative but your symptoms strongly suggest CLN4, your doctor may need to order “modified” testing or specialized targeted genetic techniques, which are better at catching these hidden variants ^[1][3].

Moving Beyond Biopsies

In the past, doctors used a skin or tissue biopsy to look for storage material under a microscope. Today, medical consensus has shifted away from this ^[4][5].

• Biopsies are Unreliable: Normal age-related “wear-and-tear” pigment (lipofuscin) looks very similar to the disease material (ceroid). This makes it easy for a biopsy to be misinterpreted ^[4].
• DNA is Preferred: A high-quality genetic test that identifies a pathogenic or likely pathogenic variant in the DNAJC5 gene, when fitting the clinical picture, is the standard for diagnosis ^[6]. Note that a Variant of Uncertain Significance (VUS) does not confirm a diagnosis.

Understanding Autosomal Dominant Inheritance

CLN4 follows a pattern called autosomal dominant inheritance. This is different from many other forms of Batten disease, which are typically recessive ^[7].

• What it means for you: You only need to inherit one copy of the mutated gene from one parent to develop the disease. In many cases, one of your parents may have had similar symptoms, though they might have been misdiagnosed with something else, like Parkinson’s or Alzheimer’s ^[7][8].
• What it means for your family: Each child of a person with CLN4 has a 50% chance of inheriting the pathogenic variant. Inheriting the variant means they are at very high risk of developing the disease in adulthood ^[7].
• Spontaneous Mutations: Occasionally, a person is the first in their family to have the mutation. This is called a de novo mutation, meaning it happened spontaneously and was not inherited from a parent ^[9].

The Role of Genetic Counseling

A genetic counselor is a vital part of your care team. They can help you:

1. Read the Report: They will check for the exact “HGVS notation” (the code that describes the mutation) and confirm it is in the cysteine-string domain of the DNAJC5 gene ^[7][1].
2. Cascade Testing: They can coordinate testing for your adult siblings or children, a process known as cascade testing ^[7]. Predictive testing of minors for an adult-onset condition is usually approached cautiously and generally avoided unless there is a childhood medical benefit.
3. Family Planning: They can discuss reproductive options, such as pre-implantation genetic testing, for family members who want to ensure they do not pass the gene to the next generation ^[7].